retatrutide glp-1 retatrutide 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide Weight Loss Results:Trial Data

For any patients presenting with compatible illness, inform the Victorian Poisons Information Centre on 13 11 26 who can provide clinical and specific testing advice

For practical patient education, this means: do not let appetite suppression cause protein neglect spread protein across the day rather than eating most of it at dinner use convenient protein sources when appetite is low tailor targets to the persons age, activity, and body composition Examples include: eggs or egg whites Greek yogurt cottage cheese chicken or turkey fish lean beef tofu or tempeh protein shakes when needed 2

Knerr PJ, Mowery SA, Douros JD, Premdjee B, Hjllund KR, He Y, et al

, The most recent published research (January 2025), a large nationwide case-time-control study using data in France, found no evidence that GLP-1 use increased short-term risk of suicide or suicide attempt in patients with obesity or history of psychiatric disorders

Its not a coincidence that early GLP-1 users are also revealing that lack of satiety has a known sensory experience which flips to becoming negative for some users of these drugs

Vanderah TW (Editor)